Aromatic amines and cancer

Cancer Causes and Control

Volumn 8, Issue 3, 1997, Pages 346-355

  Vineis, Paolo ^a   Pirastu, Roberta ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Arylamines; Bladder cancer; Occupational exposure; Tobacco

Indexed keywords

1 NAPHTHYLAMINE; 2 METHYLANILINE; 2 NAPHTHYLAMINE; 4 BIPHENYLAMINE; 4 CHLOROANILINE; 4,4' METHYLENEBIS(2 CHLOROANILINE); ACYLTRANSFERASE; ALUMINUM; ANILINE; ANILINE DERIVATIVE; AROMATIC AMINE; AURAMINE; AZO DYE; BENZIDINE; BENZO[A]PYRENE; CHLORNAPHAZINE; COAL; DIURON; DNA; FUCHSINE; HEMOGLOBIN; HERBICIDE; PESTICIDE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE;

BLADDER CANCER; CANCER RISK; CARCINOGENICITY; DNA ADDUCT; FEMALE; GENDER; GENOTYPE; HUMAN; INDUSTRY; MALE; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SMOKING;

2-NAPHTHYLAMINE; ACETYLTRANSFERASES; AIR POLLUTANTS; AMINES; BENZIDINES; BENZOPHENONEIDUM; CARCINOGENS; CASE-CONTROL STUDIES; COHORT STUDIES; COLORING AGENTS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DISINFECTANTS; ECOLOGY; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE; HUMANS; HYDROCARBONS, AROMATIC; MALE; METHYLENEBIS(CHLOROANILINE); NEOPLASMS; NITROGEN MUSTARD COMPOUNDS; OCCUPATIONAL EXPOSURE; PLANTS, TOXIC; POLYCYCLIC COMPOUNDS; RISK FACTORS; ROSANILINE DYES; SEX CHARACTERISTICS; SMOKE; SMOKING; TOBACCO; URINARY BLADDER NEOPLASMS;

EID: 0030751712     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018453104303     Document Type: Review

References (73)

1. Jeyaratnam J. Transfer of hazardous industries. In: Pearce N, Matos E, Boffetta P, Kogevinas M, eds. Occupational Cancer in Developing Countries. Oxford, UK: Oxford University Press, 1994; IARC Sci. Pub. No. 129: 23-9.
2. Maclure M, Katz RB, Bryant MS, Skipper PL, Tannenbaum SR. Elevated blood levels of carcinogens in passive smokers. Am J Public Health 1989; 79: 1381-4.
3. International Agency for Research on Cancer. Some Aromatic Amines, Hydrazine and Related Substances, N-nitrosocompounds and Miscellaneous Alkykating Agents Lyon, France: IARC, 1974; IARC Monogr Eval Risks Humans, Vol. 4.
4. US Government. Occupational Safety and Health Standards. Washington DC: US Federal Register 38, 1973; No. 85, 10929.
5. International Labour Office. Cancer of the Bladder among Workers in Aniline Factories. Geneva, Switzerland: ILO, 1921; Studies and Reports, Series F, No 1.
6. Budnick LD, Sokal DC, Falk H, Logue JN, Fox JM. Cancer and birth defects near the Drake Superfund site, Pennsylvania. Arch Environ Health 1984; 39: 409-13.
7. Dolin PJ. A descriptive study of occupation and bladder cancer in England & Wales. Br J Cancer 1992; 65: 476-8.
8. Dolin PJ, Cook-Mozzafari P. Occupation and bladder cancer: a death certificate study. Br J Cancer 1992; 66: 568-78.
9. Viel JF, Challier B. Bladder cancer among French farmers: does exposure to pesticides in vineyards play a part? Occup Environ Med 1995; 52: 587-92.
10. Hueper WC, Wiley F, Wolfe HD. Experimental production of bladder tumors in dogs by administration of betanaphthylamine. J Ind Hyg Toxicol 1938; 20: 46-84.
11. Case RAM, Flosker ME, McDonald DB, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part 1. Br J Ind Med 1954; 11: 75-104.
12. International Agency for Research on Cancer, Overall Evaluations of Carcniogenicity: an Updating of IARC Monographs Volumes 1 to 42. Lyon, France: IARC 1987; IARC Monogr Eval Risks Humans, Supplement 7.
13. Mancuso TF, El-Attar AA. Cohort study of workers exposed to beta-naphthylamine and benzidine. J Occup Med 1967; 9: 277-85.
14. Goldwater LJ, Rosso AJ, Kleinfeld M. Bladder tumors in a coal tar dye plant. Arch Environ Health 1965; 11: 814-7.
15. Schulte PA, Ringen K, Hemstreet GP, et al. Risk assessment of a cohort exposed to aromatic amines. J Occup Med 1965; 27: 115-21.
16. Rubino GF, Scansetti G, Piolatto G, Pira E. The carcinogenic effect of aromatic amines: an epidemiologic study on the role of o-toluidine and 4,4′-methylene bis(2-methylaniline) in inducing bladder cancer in man. Environ Res 1982; 27: 241-54.
17. Bulbulyan MA, Figgs LW, Zahm SH, et al. Cancer incidence and mortality among beta-naphthylamine and benzidinc dye workers in Moscow. Int J Epidemiol 1995; 24: 266-75.
18. Zavon M.R, Hoegg U, Bingham E. Benzidine exposure as a cause of bladder tumours. Arch Environ Health 1973; 27: 1-7.
19. Tsuchiya K, Okubo T, Ishizu S. An epidemiological study of occupational bladder tumors in the dye industry in Japan. Am J Ind Med 1975; 32: 203-9.
20. Horton AW, Bingham EL. Risk of bladder tumors among benzidine workers and their serum properdine levels. JNCI 1977; 58: 1225-8.
21. Meigs JW, Marrett LD, Ulrich FU, Flannery JT. Bladder tumor incidence among workers exposed to benzidine: a thirty-year follow-up. JNCI 1986; 76: 1-8.
22. Bi WF, Hayes RB, Feng P, et al. Mortality and incidence of bladder cancer in benzidine-exposed workers in China. Am J Ind Med 1992; 21: 481-9.
23. Melamed MR. Diagnostic cytology of urinary tract carcinoma. A review of experience with spontaneous and carcinogen induced tumors in man. Eur J Cancer 1972; 8: 287-92.
24. Melick WF Bladder carcinoma and xenylamine. New Engl J Med 1972; 287: 1103.
25. Zack JA, Gaffey WR. A mortality study of workers employees at the Monsanto Company plant in Nitro, West Virginia. Environ Sci Res 1983; 26: 575-91.
26. Stasik MJ. Carcinomas of the urinary bladder in a 4-chloroo-toluidine cohort. Int Arch Occup Environ Health 1988; 60: 21-4.
27. Ward E, Carpenter A, Markowitz S, Roberts D, Halperin W. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. JNCI 1991; 83: 501-6.
28. Popp W, Schmieding W, Speck M, Vahrenholz C, Norpoth K. Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidme while synthesising chlordimeform. Br J Ind Med 1992; 49: 529-31.
29. Bonassi S, Merlo F, Pearce N, Puntoni R. Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int J Cancer 1989; 44: 648-51.
30. Schumacher MC, Slattery ML, West DW. Occupation and bladder cancer in Utah. Am J Ind Med 1989; 16: 89-102.
31. Steineck G, Plato N, Alfredsson L, Norell SE. Industry-related urothehal carcinogens: application of a job-exposure matrix to census data. Am J Ind Med 1989; 16: 209-24.
32. Hours M, Dananche B, Fevotte J, et al. Bladder cancer and occupational exposure. Scand J Work Environ Health 1994; 20: 322-30.
33. Siemiatycki J, Dewar R, Nadon L, Gerin M. Occupational risk factors for bladder cancer: results from a case-control study in Montreal, Quebec, Canada. Am J Epidemiol 1994; 140: 1061-80.
34. Doll R, Vessey MP, Beasley RWR, et al. Mortality of gasworkers - final report of a prospective study. Br J Ind Med 1972; 29: 394-406.
35. Redmond CK, Ciocco A, Lloyd JW, Rush HW. Long-term mortality study of steelworkers. VI. Mortality from malignant neoplasms among coke oven workers. J Occup Med 1972; 14: 621-9.
36. Hammond EC, Selikoff IJ, Lawther PE, Seidman H. Inhalation of benzpyrene and cancer in man. Ann NY Acad Sci 1976; 271: 116-24.
37. Gustavsson P, Gustavsson A, Hogstedt C. Excess of cancer among Swedish chimney sweeps. Br J Ind Med 1988; 45: 777-81.
38. Steineck G, Norell SE, Feychting M. Diet, tobacco and urothelial cancer: a 14-year follow-up of 16,477 subjects. Acta Oncol 1988; 27: 323-7.
39. Howe GR, Burch JD, Miller AB, et al. Tobacco use, occupation, coffee, various nutrients and bladder cancer. JNCI 1980; 64: 701-13.
40. McLaughlin JK, Blot WJ, Mandel JS, Schuman EM, Mehl ES, Fraumeni JF Jr. Etiology of cancer of the renal pelvis. JNCI 1983; 71: 287-91.
41. Silverman DT, Hoover RN, Albert S, Graff KM. Occupation and cancer of the lower urinary tract in Detroit. JNCI 1983; 70: 237-45,
42. Mommsen S, Aagard J. Occupational exposures as a risk indicator of male bladder carcinoma in a predominantly rural area. Acta Radiol Oncol 1984; 23: 147-52.
43. Schoenberg JB, Stemhagen A, Mogienicki AP, Altman R, Abe T, Mason TJ. Case-control study of bladder cancer in New Jersey. I. Occupational exposures in white males. JNCI 1984; 72: 973-81.
44. Thériault G, Tremblay C, Cordier S, et al. Bladder cancer in the aluminum industry. Lancet 1984; 1: 947-50.
45. Morrison AS, Ahlbom A, Verhoek WG, Aori IL, Ohno Y, Obata K. Occupation and bladder cancer in Boston USA, Manchester, UK and Nagoya, Japan. J Epidemiol Comm Health 1985; 39: 294-300.
46. Dunham LJ, Rabson AS, Stewart HL, et al. Rates, interview, and pathology study of cancer of the urinary bladder in New Orleans, Louisiana. JNCI 1968; 41: 683.
47. Tola S, Tenho M, Korkala ML, Jarvinen E. Cancer of the urinary bladder in Finland. Int Arch Occup Environ Health 1980; 46: 43-51.
48. Vineis P, Magnani C. Occupation and bladder cancer in males: a case-control study. Int J Cancer 1985; 35: 599-606.
49. Tremblay C, Armstrong B, Thériault G, Brodeur J. Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry. Am J Ind Med 1995: 27: 335-48.
50. Steineck G, Plato N, Norell SE, Hogstedt C. Urothelial cancer and some industry-related chemicals: an evaluation of the epidemiologic literature. Am J Ind Med 1990; 17: 371-91.
51. International Agency for Research on Cancer. Occupational Exposures of Hairdressers and Barbers and Personal Use of Hair Colourants; Some Hair Dyes, Cosmetic Colorants, Industrial Dyestuff and Aromatic Amines. Lyon, France: IARC, 1993; IARC Monogr Eval Risks Humans, Vol. 57.
52. International Agency for Research on Cancer. Occupational Exposures of Hairdressers and Barbers and Personal Use of Hair Colourants; Some Hair Dyes, Cosmetic Colorants, Industrial Dyestuff and Aromatic Amines. Lyon, France: IARC, 1993; IARC Monogr Eval Risks Humans, Vol. 57.
53. Huff J. Chemicals and cancer in humans: first evidence in experimental animals. Environ Health Perspect 1993; 100: 201-10.
54. Vineis P, Simonato L. Proportion of lung and bladder cancers in males resulting from occupation: A systematic approach. Arch Environ Health 1991; 46: 6-15.
55. Vainio H, Matos E, Boffetta P, Kogevinas M. Occupational cancer in developing and newly industrialized countries. Ann Acad Med Singapore 1993; 22: 170-81.
56. Kogevinas M, Boffetta P, Pearce N. Occupational exposure to carcinogens in developing countries. In: Pearce N, Matos E, Boffetta P, Kogevinas M., eds. Occupational Cancer in Developing Countries. Oxford, UK: Oxford University Press, 1994; IARC Sci. Pub. No. 129: 63-95.
57. Xue-Yun Y, Ji-Gang C, Yong-Ning H. Studies on the relation between bladder cancer and benzidine or its derived dyes in Shanghai. Br J Ind Med 1990; 47: 544-52.
58. Zheng W, Mc Laughlin J, Gao Y, Silverman DT, Gao R, Blot WJ. Bladder cancer and occupation in Shanghai, 1980-84. Am J Ind Med 1992; 21: 877-85.
59. Notani PN, Shah P, Jayat K, Balakrishnan V. Occupation and cancers of the lung and bladder: a case-control study in Bombay. Int J Epidemiol 1993; 22: 185-91.
60. International Agency for Research on Cancer. Tobacco Smoking. Lyon, France: IARC,1986; IARC Monogr Eval Risks Humans, Vol. 38.
61. International Agency for Research on Cancer. Tobacco Smoking. Lyon, France: IARC,1986; IARC Monogr Eval Risks Humans, Vol. 38.
62. Vineis P. Epidemiological models of carcinogenesis: the example of bladder cancer. Cancer Epidemiol Biomark Prev 1992; 1: 149-53.
63. Bartsch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P. Black (air cured) and blond (flue cured) tobacco - Cancer risk IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 1993; 29A: 1199-207.
64. Talaska G, Al-Juburi AZSS, Kadlubar FF. Smoking-related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci USA 1991; 88: 5350-454.
65. Talaska G, Schamer M, Skipper P, et al. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol Biomark Prev 1991; 1: 61-6.
66. Vineis P, Talaska G, Malaveille C, et al. DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int J Cancer 1996; 65: 314-6.
67. Vineis P, Bartsch H, Caporaso N, et al. Genetically-based N-acetyltransferasc metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994; 369: 154-6.
68. D'Errico A, Taioli E, Chen X, Vineis P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1996; 1: 149-73.
69. Sköv T, Sprogel P, Engholm, Frolund C. Cancer of the lung and urinary bladder in Denmark, 1943-87: a cohort analysis. Cancer Causes Control 1991; 2: 365-9.
70. Hartge P, Harvey EB, Linehan WM, et al. Unexplained excess risk of bladder cancer in men. JNCI 1990; 82: 1636-40.
71. Anton-Culver H, Lee-Feldstein A, Taylor TH. The association of bladder cancer risk with ethnicity, gender and smoking. Ann Epidemiol 1993; 3: 429-33.
72. Cantor KP, Lynch CF, Johnson D. Bladder cancer, parity and age at first birth. Cancer Causes Control 1992; 3: 57-62.
73. Fenech M, Neville S, Rinaldi J. Sex is an important variable affecting spontaneous micronucleus frequency in cytokinesis-blocked lymphocytes. Mutation Res 1994; 313: 203-7.